Cormorant Asset Management, LP sold $1.7M of Corbus Pharmaceuticals (CRBP)

Executed Oct 29, disclosed Nov 2, 4 days later.

Value, as filed

$1.7M

425,000 sh × $4.10

Executed

Oct 29

the trade date, as filed

Disclosed

Nov 2

4 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

CL Cormorant Asset Management, LP Other profile →

Cormorant Asset Management, LP (Other) filed 3 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 3 sales), most often in Corbus Pharmaceuticals Holdings, Inc. (CRBP). The largest single filing was $9.8M of DRUG (109,331 sh × $89.50, as filed), executed Apr 28.

The name

CRBP

Corbus Pharmaceuticals Holdings, Inc. CRBP · Healthcare · 7 filings in 24 months ticker →

Healthcare · Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→